Physician profile
Alan Dang
NPI 1659049583
$2,018.91
in general payments reported to CMS, 2019-2025
10 companies · $74.34 in 2025
The $74.34 reported for 2025 was less than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $519 · 2023: $306 · 2024: $1,120 · 2025: $74.34.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,499.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $1,002.22 | 2022-2025 | Impella |
| Medtronic, INC. | $299.11 | 2024 | Linq II, Endurant Iis |
| Inari Medical, INC. | $192.43 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $154.18 | 2022-2024 | Jardiance |
| W. L. Gore & Associates, INC. | $153.42 | 2024 | Gore Tag Thoracic Branch Endoprosthesis |
| Baxter Healthcare | $105.42 | 2024 | Perclot, Floseal |
| Shionogi INC | $33.84 | 2022 | |
| Atricure, INC. | $32.14 | 2024 | |
| Grifols USA, LLC | $25.85 | 2022 | |
| La Jolla Pharmaceutical Company | $20.30 | 2024 | Giapreza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Dang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.